OCT 02, 2019 8:00 AM PDT

Surface Plasmon Resonance (SPR) Technology

SPONSORED BY: Reichert Technologies

Surface plasmon resonance (SPR) allows researchers to investigate different types of biomolecular interactions and mechanisms in real-time and label-free. With SPR, you can not only determine if there is an interaction with your target molecule but can also measure how strong and specific the interaction is.  

Whether you are studying Alzheimer’s disease, developing new vaccines, or discovering small molecules for cancer therapy, SPR can help you quickly identify if there is an exciting interaction worth studying further.

Learn how you can advance your research with Reichert SPR technology in the infographic below.

"Copy + Paste" the code below to embed this infographic into your website.

About the Sponsor
Reichert Technologies, a unit of AMETEK, Inc., is a global leader in the design, engineering, development, and manufacture of eye care, analytical and life science instruments and medical devices.
You May Also Like
JUN 09, 2017
Infographics
Diamonds are Forever, or Are They?
JUN 09, 2017
Diamonds are Forever, or Are They?
N.W. Ayer, the advertising agency hired by De Beers in the late 1940’s, coined the phrase, “A diamond is for ...
DEC 27, 2017
Infographics
Are Digital Screens Affecting Your Health?
DEC 27, 2017
Are Digital Screens Affecting Your Health?
Digital screens are quickly becoming integrated into all aspects of our daily lives. The average American spends 11 hour ...
FEB 22, 2019
Health & Medicine
Medical Marijuana
FEB 22, 2019
Medical Marijuana
The marijuana (cannabis) plant has been used for recreational and medicinal purposes for more than 4,000 years. It was i ...
APR 23, 2019
Health & Medicine
Cancer Immunotherapy
APR 23, 2019
Cancer Immunotherapy
Every year there are an estimated 14.1 million new cases and 8.2 million cancer-related deaths worldwide. Cancer therapi ...
OCT 29, 2021
Infographics
Can We Treat Alzheimer's?
OCT 29, 2021
Can We Treat Alzheimer's?
Alzheimer's is the most common form of dementia, an umbrella term for different kinds of cognitive decline inlcuding ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
Loading Comments...